Cogent Biosciences Inc
NASDAQ:COGT
Cogent Biosciences Inc
Total Other Income
Cogent Biosciences Inc
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cogent Biosciences Inc
NASDAQ:COGT
|
Total Other Income
$262k
|
CAGR 3-Years
-68%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$4.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-204%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$252m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$15.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cogent Biosciences Inc's Total Other Income?
Total Other Income
262k
USD
Based on the financial report for Mar 31, 2024, Cogent Biosciences Inc's Total Other Income amounts to 262k USD.
What is Cogent Biosciences Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
12%
Over the last year, the Total Other Income growth was -95%. The average annual Total Other Income growth rates for Cogent Biosciences Inc have been -68% over the past three years , 12% over the past five years .